Who
Chad J. Swanson
Chief Development Officer
Company insider
Files Form 4 as: Chief Development Officer, Prothena Corporation.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Oct 2024
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code M | —51,000 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code D | $349K40,800 at $8.56 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code F | $30K3,467 at $8.56 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —51,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —51,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code M | —51,000 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code D | $349K40,800 at $8.56 | filing |
| 28 Jul 2026filed 30 Jul 2026 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code F | $30K3,467 at $8.56 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 28 Jul 2025filed 30 Jul 2025 | PRTA Prothena CorporationBiotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,500 at $0.00 | filing |
| 1 Oct 2024filed 3 Oct 2024 | PRTA Prothena Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.